GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » Debt-to-Equity

Kinarus Therapeutics Holding AG (XSWX:KNRS) Debt-to-Equity : -1.07 (As of Dec. 2021)


View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG Debt-to-Equity?

Kinarus Therapeutics Holding AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was CHF0.00 Mil. Kinarus Therapeutics Holding AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was CHF0.43 Mil. Kinarus Therapeutics Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2021 was CHF-0.40 Mil. Kinarus Therapeutics Holding AG's debt to equity for the quarter that ended in Dec. 2021 was -1.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Kinarus Therapeutics Holding AG's Debt-to-Equity or its related term are showing as below:

XSWX:KNRS's Debt-to-Equity is not ranked *
in the Transportation industry.
Industry Median: 0.55
* Ranked among companies with meaningful Debt-to-Equity only.

Kinarus Therapeutics Holding AG Debt-to-Equity Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG Debt-to-Equity Chart

Kinarus Therapeutics Holding AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.97 -1.83 -1.09 -1.07

Kinarus Therapeutics Holding AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.83 -1.27 -1.09 -1.05 -1.07

Competitive Comparison of Kinarus Therapeutics Holding AG's Debt-to-Equity

For the Airports & Air Services subindustry, Kinarus Therapeutics Holding AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kinarus Therapeutics Holding AG's Debt-to-Equity Distribution in the Transportation Industry

For the Transportation industry and Industrials sector, Kinarus Therapeutics Holding AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Kinarus Therapeutics Holding AG's Debt-to-Equity falls into.



Kinarus Therapeutics Holding AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Kinarus Therapeutics Holding AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Kinarus Therapeutics Holding AG's Debt to Equity Ratio for the quarter that ended in Dec. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kinarus Therapeutics Holding AG  (XSWX:KNRS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Kinarus Therapeutics Holding AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Traded in Other Exchanges
N/A
Address
3, Avenue de Florimont, Lausanne, CHE, CH-1006
Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines